dc.contributor.author |
Mauz, Paul-Stefan |
|
dc.date.accessioned |
2023-08-28T07:35:43Z |
|
dc.date.available |
2023-08-28T07:35:43Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
0923-7534 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/145024 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.annonc.2022.12.008 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230619000000_01092 |
|
utue.publikation.seiten |
262-274 |
de_DE |
utue.personen.roh |
Psyrri, A. |
|
utue.personen.roh |
Fayette, J. |
|
utue.personen.roh |
Harrington, K. |
|
utue.personen.roh |
Gillison, M. |
|
utue.personen.roh |
Ahn, M. -J. |
|
utue.personen.roh |
Takahashi, S. |
|
utue.personen.roh |
Weiss, J. |
|
utue.personen.roh |
Machiels, J. -P. |
|
utue.personen.roh |
Baxi, S. |
|
utue.personen.roh |
Vasilyev, A. |
|
utue.personen.roh |
Karpenko, A. |
|
utue.personen.roh |
Dvorkin, M. |
|
utue.personen.roh |
Hsieh, C. -Y. |
|
utue.personen.roh |
Thungappa, S. C. |
|
utue.personen.roh |
Segura, P. P. |
|
utue.personen.roh |
Vynnychenko, I. |
|
utue.personen.roh |
Haddad, R. |
|
utue.personen.roh |
Kasper, S. |
|
utue.personen.roh |
Mauz, P. -S. |
|
utue.personen.roh |
Baker, V. |
|
utue.personen.roh |
He, P. |
|
utue.personen.roh |
Evans, B. |
|
utue.personen.roh |
Wildsmith, S. |
|
utue.personen.roh |
Olsson, R. F. |
|
utue.personen.roh |
Yovine, A. |
|
utue.personen.roh |
Kurland, J. F. |
|
utue.personen.roh |
Morsli, N. |
|
utue.personen.roh |
Seiwert, T. Y. |
|
dcterms.isPartOf.ZSTitelID |
Annals of Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
34 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |